Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...
Recent research is looking at the way in which cardiovascular issue may play into the development of dementia, with one study suggesting that heparin, a common anticoagulant, may help delay ...
Last month, the FDA granted approval to Eli Lilly’s donanemab - or Kisunla - for the treatment of Alzheimer’s disease ... hope” to patients where there has in the past “been little ...
A leading dementia expert has expressed optimism that a cure for Alzheimer's disease will ... memory clinics in the world in Melbourne and yet there was very little difference between that and ...